2021
DOI: 10.1007/s11101-021-09766-0
|View full text |Cite
|
Sign up to set email alerts
|

Biosynthesis of paclitaxel using synthetic biology

Abstract: Paclitaxel is a tricyclic diterpenoid first isolated from the bark of Taxus brevifolia. It is notably one of the most effective natural anticancer drugs discovered so far, and has been widely used in the treatment of breast, ovarian, lung cancer, as well as other diseases. However, the content of paclitaxel in the bark of yew trees is extremely low, thus alternative sources need to be developed urgently to meet the clinical demands. Using methods of synthetic biology to realize the heterologous expression of p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 99 publications
0
11
0
2
Order By: Relevance
“…Synthetic biology aims to redesign metabolic pathways and broaden the spectrum of products (e.g., protocatechuic acid, paclitaxel, opioids) ( Guan et al, 2020 ; Tong et al, 2021 ; Zhang et al, 2021 ). However, the new substrates and products usually affect the performance of these artificial cell factories.…”
Section: Adaptation To Improve Microbial Performancementioning
confidence: 99%
“…Synthetic biology aims to redesign metabolic pathways and broaden the spectrum of products (e.g., protocatechuic acid, paclitaxel, opioids) ( Guan et al, 2020 ; Tong et al, 2021 ; Zhang et al, 2021 ). However, the new substrates and products usually affect the performance of these artificial cell factories.…”
Section: Adaptation To Improve Microbial Performancementioning
confidence: 99%
“…Accordingly, the Taxol supply problem has now been completely solved by these two approaches. The topic of Taxol production has also been discussed in several reviews, , and this section has thus been abbreviated.…”
Section: Introductionmentioning
confidence: 99%
“…Paclitaxel biosynthesis in Taxus is a complex metabolic pathway that requires at least 19 enzymatic steps and more than 20 enzymes [ 11 , 12 ]. To date, this pathway has 13 identified enzymes, including one taxadiene synthase (TS), which cyclizes the diterpenoid precursor geranylgeranyl diphosphate (GGPP) into taxadiene [ 13 ]; five cytochrome P450 (CYP450) hydroxylases (T5αH, T10βH, T2αH, T7βH, and T13αH) [ 14 16 ] and five acyltransferases (TAT, TBT, DBAT, BAPT, and DBTNBT) [ 17 19 ], which decorated the taxane skeleton to form the final product paclitaxel; and two enzymes (PAM and T2′OH) in the β-phenylalanoyl side chain [ 20 ].…”
Section: Introductionmentioning
confidence: 99%